by Rachel Montague | Feb 2, 2019 | Industry insights
Written by Julie Fricke (Systematic Review Analyst) and Neil Webb (Head of Systematic Review) As described in the Cochrane Collaboration Handbook, a systematic literature review (SLR) attempts to collate all empirical evidence that fits pre-specified eligibility...
by Rachel Montague | Feb 2, 2019 | Industry insights
Written by Elise Elvers, Health Economist The Boston-based Institute for Clinical and Economic Review, otherwise known as ICER, has caught the attention of important stakeholders in the past few years. Between reports for high-impact drugs that have stirred public...
by Rachel Montague | Jan 2, 2019 | Industry insights
Written by Neil Webb, Head of Systematic Review The search strategy is the foundation of a well-conducted systematic literature review (SLR) and is the fundamental element that can affect the overall quality of the results of the final review (1, 2). The aim of a...
by Rachel Montague | Jan 2, 2019 | Industry insights
Written by Fionn Woodcock, Senior Consultant Health Economist The standard survival analysis techniques used in oncology modelling, such a parametric survival curves, provide a useful way of estimating transition probabilities to populate economic models. These models...
by Rachel Montague | Jan 2, 2017 | Industry insights
Written by David Trueman, Director htasurv is an open source Stata module for assessing alternative parametric distributions when extrapolating survival data for use in health economic models. The function distfind loops through alternative distributions (specified by...
by Rachel Montague | Oct 2, 2016 | Industry insights
Written by Juliet Mumby-Croft, Director The following pointers aim to provide practical guidance to strengthen the communication of your economic case, avoid the introduction of mistakes and make the deadline. Validate your model first. Then get someone else to...
